- Preparing For Appointments
- Contact Us
- Maps and Directions
- Clinical Trials
- Our Physicians
- Frequently Asked Questions
Events & Groups:
Join Us On Facebook.
Follow us on Twitter.
Clearview News Wire
Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.
Experts warn of cancer linked to certain herbs
Last Updated: 2009-12-21 16:33:31 -0400 (Reuters Health)December 22, 2009
HONG KONG (Reuters) - The consumption of popular Chinese herbal products containing aristolochic acid is associated with an increased risk of urinary tract cancer, a study in Taiwan has found.Aristolochic acid, known as Mu Tong in Chinese, is found naturally in some herbs that are used in Chinese herbal products to treat hepatitis, urinary tract infection, rhinitis, dysmenorrhea and eczema.
While studies in the past have linked urothelial cancer to the use of aristolochic acid, this is the first study to see if the same association can be made between cancer and herbal products containing aristolochic acid.
In the new study, researchers in Taiwan analysed the medical history of 4,594 patients with urinary tract cancer and compared the findings with those of 174,701 other people without the disease.
In a paper published in the Journal of the National Cancer Institute, the researchers said those who consumed Mu Tong had a far higher risk of developing urinary tract cancer, and the level of risk rose the higher the dosages prescribed.
Led by Jung-Der Wang at the Institute of Occupational Medicine and Industrial Hygiene in National Taiwan University, the researchers called for a ban on products containing Mu Tong.
"In addition to a ban on products that contain any amount of aristolochic acid, we also recommend continued surveillance of herbs or Chinese herbal products that might be adulterated with aristolochic acid-containing herbs," they wrote.
"Finally, patients with a history of aristolochic acid nephropathy or consumption of Mu Tong or Fangchi before they were banned should be monitored regularly for urinary cancer."
The Journal of the National Cancer Institute is published by Oxford University Press.
Other Articles:
- July 27, 2010
- Low-risk prostate cancer treated aggressively
- July 22, 2010
- California city approves marijuana farming
- July 22, 2010
- No Pap smears for women under 21: guidelines
- July 21, 2010
- Darker skin doesn't mean melanoma immunity
- July 21, 2010
- New study backs Avastin in lung cancer
- July 19, 2010
- Americans turn cold shoulder to sunscreen: poll
- July 19, 2010
- Lung cancer often recurs more than 5 years after resection
- July 16, 2010
- U.S. cancer group endorses newer breast cancer drugs
- July 15, 2010
- Palliative care lacking in much of the world
- July 12, 2010
- Fish oil might lower breast cancer risk
- July 12, 2010
- Study finds prostate screening cuts cancer deaths
- June 29, 2010
- Cancer survivors are often parents of youngsters